SAHA SAURABH 4
4 · Centessa Pharmaceuticals plc · Filed Feb 4, 2025
Insider Transaction Report
Form 4
SAHA SAURABH
DirectorChief Executive Officer
Transactions
- Award
Share Option (right to buy)
2025-02-03+900,000→ 900,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (900,000 underlying) - Tax Payment
Ordinary Shares
2025-02-01$16.92/sh−43,381$734,007→ 386,017 total
Holdings
- 38,000(indirect: By Trust)
Ordinary Shares
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]These shares are held directly in a trust, for which the Reporting Person and his spouse serve as trustees.
- [F4]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.